113. Front Oncol. 2018 Apr 5;8:83. doi: 10.3389/fonc.2018.00083. eCollection 2018.Personalizing Breast Cancer Irradiation Using Biology: From Bench to theAccelerator.Azria D(1)(2)(3), Brengues M(1), Gourgou S(3), Bourgier C(1)(2)(3).Author information: (1)Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194,Montpellier, France.(2)Université de Montpellier, Montpellier, France.(3)Institut Régional du Cancer de Montpellier (ICM), Montpellier, France.While adjuvant treatments of early breast cancers (BCs) had significantlyimproved patients' overall survival, some of them will still develop locoregionalrelapses and/or severe late radio-induced toxicities. Here, we propose to review how to personalize locoregional treatment by identifying patients at high and lowrisk of locoregional relapse, patients at risk of late radio-induced sideeffects. We will, therefore, discuss how to enhance BC radiosensitivity. Finally,we will address how personalized radiotherapy could be implemented in prospectiveclinical trials.DOI: 10.3389/fonc.2018.00083 PMCID: PMC5895767PMID: 29675397 